Skeletal requirements for optimal growth hormone replacement in the transitional years.
In addition to its well-established effects on linear growth in childhood and adolescence, growth hormone (GH) has both direct and indirect actions on bone remodelling and homeostasis. In this review, the discussion begins with the influence of childhood-onset growth hormone deficiency (CO-GHD) on bone mineral accretion. The limitations of methods of assessing bone mineral density (BMD) are highlighted and specific influential factors, which affect peak bone mass achievement and therefore skeletal health in later life, are evaluated.
Mukherjee
Annice
A
Department of Endocrinology, Christie Hospital, Wilmslow Road, Withington, Manchester, UK. stephen.m.shalet@man.ac.uk
Attanasio
Andrea F
AF
Shalet
Stephen M
SM
D000293:Adolescent; D000328:Adult; D000375:Aging; D015519:Bone Density / Q000187:drug effects*; D001846:Bone Development; D016723:Bone Remodeling; D002648:Child; D020249:Hormone Replacement Therapy; D019382:Human Growth Hormone / Q000008:administration & dosage / Q000172:deficiency* / Q000627:therapeutic use*; D006801:Humans; D007018:Hypopituitarism / Q000188:drug therapy / Q000503:physiopathology
D019382:Human Growth Hormone